Detalhe da pesquisa
1.
Serum TGF-ß1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD.
J Immunol Res
; 2023: 1535484, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37383609
2.
Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study.
PLoS One
; 17(12): e0277576, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36584073
3.
Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy.
Front Cell Infect Microbiol
; 12: 1064537, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36704107
4.
Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy.
Cells
; 10(11)2021 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34831411